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I
'n vertebrates, many different processes as diverse as growth, . vision, and reproduction are vitamin A (retinol) dependent (1) . Retinol is the source for a number of metabolites that are adapted to specific functions, such as 11.cis retinal in vision (2) or 9-cis and all-trans retinoic acid for differentiation of a,number of cellular systems (3) . The general mechanism of action of retinoids presumably is connected with their specific binding proteins. The retinoic acids serve as ligands for a group of nuclear receptor molecules termed RAK and RXK (4) (5) (6) . These receptors represent transcription factors akin to the much larger family of steroid receptors (7) . They have in common a modular structure that includes zinc fingerand ligand-binding domains. On the basis of genetic homologies, a number of "orphan" receptors have recently been identified, so-caUed because of similar modular design, but lack of knowledge of the respective ligands. Thus it is possible that a large family of lipophilic molecules evolved from primordial compounds in parallel to the superfamily of steroid/retinoic acid receptors.
Retinol can be regarded as a pro-hormone from which several effector molecules are derived. In whole animal experiments, retinol could not be replaced by retinoic acid to reverse all symptoms of vitamin A deficiency (8) . For instance, neither the profound immune dysfunction nor male sterility resulting from vitamin A deprivation was ameliorated by retinoic acid repletion (9) (10) (11) . Thus other metabolites of retinol, effective in the development of lymphoid cells and spermatocytes, have long been postulated. The first such effector molecule, 14-hydroxy-retro-retinol (14-HRK) 1 (12), was discovered among the endogenous retinoids of normal and transformed lymphocytes. It had the outstanding ability to substitute for retinol in its role as a required cofactor for activation and growth of lymphocytes in culture, and is presumed to be the active mediator of the retinol effect in this system (13). 14-HRR has been found in a variety of tissues and spedes extending as far back in evolution as fruit flies (our unpublished results). This remarkable conservation might point to a central physiological function. In fact, many transformed lymphoid cells deprived of 14-HRR after retinol withdrawal cease to proliferate and die (14, 15) . However, at this time the mechanism of action of 14-HRR is unknown, although by analogy to the retinoic adds, the role as a ligand for a cytoplasmic or nuclear receptor is more than likely. This concept received strong support in this report with the discovery of a second endogenous retinoid of lymphocytes with retro structure, anhydroretinol (AR), which functions as a competitive inhibitor of 14-HRR and which might bind to the same receptor protein.
1 Abbreviations used in this paper: AK, anhydroretinol; CRABP-1, cellular retinoic acid binding protein 1; CRBP-1, cellular retinol binding protein 1; 14-HRR, 14-hydroxy-retro-retinol; ITBL, insulin, transferrin, linoleic acid, and bovine albumin medium; RBP, retinol binding protein.
Materials and Methods

A
Cells and Cell Cultures. The lymphoblastoid cell line 5/2 was 2sooo-derived in our laboratory from a healthy volunteer by transformation with EBV. It was propagated in RPMI 1640 medium supplemented with 7% fetal bovine serum. Where indicated as sernmflee culture, the medium contained RPMI 1640 supplemented with 12so0-8 x 10 -7 M insulin, 7 x 10 -s M transferrin, 2 x 10 -4 M linoleic acid, 2 x 10-6 M delipidated BSA, 2 mM t-glutamine, 1 mM sodium pyruvate, and antibiotics (referred to as ITBL medium "-" 3s000-New England Nuclear (Boston, MA). AR was isolated from the -rcell line SF 21 as follows: 10 liters of cell suspension were incubated ~' with 10 -s M retinol overnight at 26~ The cell pellet was extracted by the method of McClean et al. (16) . The extract was chros0o0o-" matographed on a preparative Cls HPLC column using a water/ C methanol/chloroform gradient. The three cis-trans isomers of AR eluting at 92% methanol/8% water were pooled. A second run on an analytical Cls column fielded pure AR. Its UV spectrum showed a characteristic vibronic fine structure with maxima at 351, asoo0-368, and 390 nm (17, 18) . Mass spectroscopy and proton nuclear magnetic resonance confirmed the structure (Derguini, F., manuscript in preparation).
Synthetic AR produced by acid catalyzed dehydration ofall-trans retinol (18) was used for bioassays. Synthetic AR was purified by o the same HPLC chromatographic procedure described above. 14-
hydroxy-retro-retinol was isolated from pellets of HeLa cells as described (12).
B CeUProliferation and T CellActivation Assays. These were carried out as described in detail by Garbe et al. (13) .
Retinoid Binding Proteins.
Human cellular retinol binding protein 1 (CRBP-1) and cellular retinoic acid binding protein 1 (CRABP-1) were gifts from Drs. W. S. Blaner (Columbia University) and J. Napoli (State University of New York, Buffalo, NY), respectively.
Results and Discussion
Among the metabolites of retinol extracted from B lymphoblastoid cells and chromatographically separated on an HPLC Cls column with a water/methanol/chloroform gradient ( Fig. 1 C) , we noted the presence of a retinoid with relatively hydrophobic properties, eluting in the particular gradient system used at minute 29. Two minor companions at minutes 28 and 27 are likely cis/trans isomers of the same compound. The three peaks exhibited nearly identical UV absorption spectra with vibronic fine structure and maxima at 351, 368, and 390 nm indicating a retro-retinoid skeleton with six double bonds. A chance observation of overproduction of an identical retinoid in a subline of the Drosophila $2M3 cell line allowed us to isolate this retinoid in quantity and to determine its structure as AR on the basis of mass and nuclear magnetic resonance spectroscopy, as will be described elsewhere (Derguini, F., manuscript in preparation) (see structure 3 in Fig. 1 ). AR synthesis is dependent on an cell line of Spodopterafrugiperda produces AR as the predominant retinol metabolite, whereas a subclone of this line, SF 9, does not produce detectable amounts of AR. Thus, AR does not appear to arise from spontaneous dehydration but is enzymatically derived. In the test tube, however, AR is easily synthesized from retinol by acid-catalyzed dehydration (18) .
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• 100. - (Fig. 2 A) . On the contrary, AR proved to behave as a competitive inhibitor, leading to cell death. The inhibitory effect was dose dependent, but depended on the retinol status of the cultures and on the time of measurement. Inhibition was most pronounced, requiring a minimum dose of AlL of 3 x 10-7 M and a culture time of 3 d to essentially kill all cells, when no other retinoid was added to the medium (Fig. 2 A) , whereas 1 d after onset of culture complete inhibition required a 10-fold-higher dose of AR (Fig. 2 B) . The inhibitory effect of AR was counteracted effectively by retinol (Fig. 2 A) or 14-HRR (Fig. 2  B) , and in both cases, the relative concentrations of agonist (retinol or 14-HRR) and antagonist (AR) determined the outcome, i.e., proliferation versus cell death. The inhibition curves shown are typical for reversible inhibition of a pharmacological agent and imply competition for a common receptor molecule. AR was also capable of reversibly inhibiting lymphoblastoid B cells grown under more physiological conditions in serum-containing medium (Fig. 2 C) . Several other randomly selected lymphoblastoid B cell lines were also found to be sensitive to inhibition with AR (Fig. 2 D) . So far we have encountered no exception among many more lines tested, including freshly EBV-transformed B lymphocytes, indicating a general dependence among B cells on 14-HRR as growthpromoting agonist and corresponding susceptibility to AR as an antagonist.
Activation of resting thymocytes by TClL-generated signals in serum-free medium was previously shown to be dependent on retinoid cofactors, retinol, or 14-HRR (13) . To test whether AR would interfere with this process as well, murine thymocytes were stimulated in ITLB medium with immobilized anti-CD3e antibody and retinol or 14-HRlL as cofactors, and various concentrations of AR. Inhibition of thymocyte activation was pronounced, depending on the relative concentrations of agonist (i.e., retinol or 14-HlLR) and AR, as illustrated by the series of dose-response curves in Fig. 3, A and B . The interrelationship between agonist and antagonist was comparable to that observed in B lymphocytes. AR not only prevented the activation of thymocytes, but was also able to reduce the thymidine uptake of cycling thymocytes if given 2 d after activation (Fig. 3 C) .
Cyclosporine A and FK 506 block IL-2 release and the expression of IL-2 receptor and prevent the activation of CD4 + T lymphocytes (21, 22) . We knew from previous unpublished work that both IL-2 production and IL-2 receptor expression were unaffected by the presence or absence of retinol or 14-HRR. Therefore, as expected, AIL did not interfere with IL-2 release, as shown in Fig. 3 D. This is an important control experiment to indicate that the AlL effect on proliferation is not due to generalized toxicity.
A common feature in the physiology of retinoids is the use of intracellular and extracellular binding proteins, often specialized for particular retinoids, for protection against oxidative degradation and for transport. All three retinoids tested bind to RBP of plasma and to CRBP-1 (Table 1) , but the affinities of retinol and AlL are 10-fold higher than those of 14-HRlL (23) . Given these circumstances, competitive inhibition at the level of CRBP-I may explain the retinol-AlL antagonism. For instance, if the CRBP-1/retinol complex were required for 14-HRR biosynthesis, its disruption by the AlL antagonist might interfere with this step. However, we found (26) . Human RBP was purified from human serum by means of a transthyretin column (27) .
no change in the metabolic rate of 14-HRR synthesis from 3H-labeled retinol in the presence of a 100-fold excess of AlL (data not shown). Moreover, the promyelocytic cell line HL-60 fails to express CRBP-1 but is nonetheless susceptible to reversible growth inhibition by AR (Eppinger, T., J. Buck, and U. H~-amerling, unpublished observations). We conclude that CRBP-1 is not involved in the biological retinol-AR antagonism. Moreover, the facts that 14-HlLR binds to CRBP-1 with appreciably lower affinity (Table 1) and that AR also reversibly inhibits cultures of lymphocytes when 14-HRR is provided as an agonist (Figs. 2 B and 3 , B) imply antagonism at a point downstream of, or in addition to, CRBP-1. A separate 14-HRR/AR binding protein/receptor, as yet to be defined, is inferred. The demonstration that AR acts as antagonist to retinol and, especially, to 14-HRR contributes to the understanding of the mechanism of action of these retinoids. First, the pharmacological reversibility is best explained by competition of two structurally closely related compounds for the same receptor. Second, 14-HRR and AR occur in mammalian and insect cells, thus suggesting conservation of a complex family of retro-retinoids over a long evolutionary period. Third, AR has been observed by us as a natural product of B lymphocytes and therefore the positive signaling action of 14-HRR and the negative one of AR may be meaningful for lymphocyte physiology. To our knowledge, 14-HRR and AR constitute the first naturally occurring agonist/antagonist pair of retinoids (or other small lipophilic messenger molecules) to be described. Fourth, the retro-retinoid pathway is essential for T cell activation, but appears to operate independently of the calcineurin/IL-2 pathway. AR might presage the development of new types of immunosuppressive and/or antiproliferative agents.
